These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30030040)

  • 21. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacists.
    Tata V; Varisco TJ; Du N; Nguyen J; Haghparast P; Thornton JD
    J Am Pharm Assoc (2003); 2021; 61(3):316-324. PubMed ID: 33579594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescription drug monitoring programs in community pharmacy: An exploration of pharmacist time requirements and labor cost.
    Upton C; Gernant SA; Rickles NM
    J Am Pharm Assoc (2003); 2020; 60(6):943-950. PubMed ID: 32792293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacists' Experiences, Perceptions, and Attitudes towards Suicide and Suicide Prevention: A Scoping Review.
    Kamal L; Jacob SA
    Pharmacy (Basel); 2023 Jan; 11(1):. PubMed ID: 36827663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists.
    Alley L; Novak K; Havlin T; Irwin AN; Carson J; Johnston K; O'Kane N; Hartung DM
    Res Social Adm Pharm; 2020 Oct; 16(10):1422-1430. PubMed ID: 31953112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do researchers use pharmacists' communication as an outcome measure? A scoping review of pharmacist involvement in diabetes care.
    Babinec PM; Rock MJ; Lorenzetti DL; Johnson JA
    Int J Pharm Pract; 2010 Aug; 18(4):183-93. PubMed ID: 20636669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Florida physicians' knowledge and attitudes toward accessing the state prescription drug monitoring program as a prescribing tool.
    Gershman JA; Gershman JA; Fass AD; Popovici I
    Pain Med; 2014 Dec; 15(12):2013-9. PubMed ID: 24931295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Multistep Approach to Address Clinican Knowledge, Attitudes, and Behavior Around Opioid Prescribing.
    Kohlbeck S; Akert B; Pace C; Zosel A
    WMJ; 2018 Mar; 117(1):38-41. PubMed ID: 29677414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of community pharmacist therapeutic knowledge of dietary supplements.
    Waddington F; Naunton M; Kyle G; Thomas J; Cooper G; Waddington A
    Int J Clin Pharm; 2015 Jun; 37(3):439-46. PubMed ID: 25763901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):396-406. PubMed ID: 22362493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provider perspectives and experiences following the integration of the prescription drug monitoring program into the electronic health record.
    Witry M; Marie BS; Reist J
    Health Informatics J; 2022; 28(3):14604582221113435. PubMed ID: 35829729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resident Access to the St. Louis County Prescription Drug Monitoring Program: Why PDMPs Matter and How to Gain Access.
    Lange J; Gaddis G; Varner E; Schmidt S; Cohen R; Schwarz E
    Mo Med; 2018; 115(6):487-493. PubMed ID: 30643325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge, attitudes, perceptions and habits towards antibiotics dispensed without medical prescription: a qualitative study of Spanish pharmacists.
    Vazquez-Lago J; Gonzalez-Gonzalez C; Zapata-Cachafeiro M; Lopez-Vazquez P; Taracido M; López A; Figueiras A
    BMJ Open; 2017 Oct; 7(10):e015674. PubMed ID: 28993379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review.
    Kwan D; Hirschkorn K; Boon H
    BMC Complement Altern Med; 2006 Sep; 6():31. PubMed ID: 16984649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.
    Rhodes E; Wilson M; Robinson A; Hayden JA; Asbridge M
    BMC Health Serv Res; 2019 Nov; 19(1):784. PubMed ID: 31675963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
    Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research to support optimization of prescription drug monitoring programs.
    Doyle S; Leichtling G; Hildebran C; Reilly C
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1425-1427. PubMed ID: 28905438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.